Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease
2011
Lipid Abnormalities and Cardiometabolic Risk in Thyroid Disease
publication
Evidence: moderate
Author Information
Author(s): Peppa Melpomeni, Betsi Grigoria, Dimitriadis George
Primary Institution: Athens University Medical School, Attikon University Hospital, Athens, Greece
Hypothesis
Thyroid disease is associated with dyslipidemia and increased cardiovascular risk.
Conclusion
Thyroid hormones affect lipid metabolism, leading to dyslipidemia and increased cardiovascular risk.
Supporting Evidence
- Dyslipidemia is common in thyroid disease, affecting cholesterol and triglyceride levels.
- Thyroid hormones influence lipid metabolism, leading to various lipid abnormalities.
- Dyslipidemia in thyroid disease is linked to increased cardiovascular risk.
Takeaway
People with thyroid problems often have issues with their cholesterol and fats in the blood, which can make their hearts sick.
Limitations
More studies are needed to clarify the significance of dyslipidemia in thyroid disease.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website